Literature DB >> 17617490

Panel advises against rimonabant approval.

Kate Traynor.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17617490     DOI: 10.2146/news070065

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  8 in total

1.  Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.

Authors:  Julie A Marusich; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2012-03-09       Impact factor: 3.533

2.  (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs.

Authors:  Mariam M Mahmoud; Teresa Olszewska; Hui Liu; Derek M Shore; Dow P Hurst; Patricia H Reggio; Dai Lu; Debra A Kendall
Journal:  Mol Pharmacol       Date:  2014-11-19       Impact factor: 4.436

3.  Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.

Authors:  Brian D Kangas; Marcus S Delatte; V Kiran Vemuri; Ganesh A Thakur; Spyridon P Nikas; Kumara V Subramanian; Vidyanand G Shukla; Alexandros Makriyannis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2013-01-03       Impact factor: 4.030

4.  Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.

Authors:  Sara Jane Ward; Timothy W Lefever; Scott M Rawls; Garth T Whiteside; Ellen A Walker
Journal:  Psychopharmacology (Berl)       Date:  2009-07-03       Impact factor: 4.530

5.  Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice.

Authors:  Sara Jane Ward; Ellen A Walker
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

6.  Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats.

Authors:  Yuanyuan Ding; Yanyan Qiu; Li Jing; David A Thorn; Yanan Zhang; Jun-Xu Li
Journal:  Pharmacol Res Perspect       Date:  2014-08-24

7.  Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression.

Authors:  Mario Stampanoni Bassi; Luana Gilio; Pierpaolo Maffei; Ettore Dolcetti; Antonio Bruno; Fabio Buttari; Diego Centonze; Ennio Iezzi
Journal:  Front Mol Neurosci       Date:  2018-11-20       Impact factor: 5.639

Review 8.  Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.

Authors:  Krzysztof Laudanski; Justin Wain
Journal:  J Clin Med       Date:  2022-01-22       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.